Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/LCTX stock hub

TLV/LCTX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TLV/LCTXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
990.1M
Tel Aviv Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TLV/LCTX
In the news

Latest news · TLV/LCTX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-105.3
P25 n/aP50 n/aP75 n/a
ROIC-21.7
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TLV/LCTX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
177
Groups with data
11
Currency
USD
Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
IL
Employees
75
Employees Change
0%
Employees Change Percent
0
Enterprise value
ILA 831.9M
Exchange
Tel Aviv Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Isin
US53566P1093
Last refreshed
2026-05-10
Market cap
ILA 990.1M
Price
ILA 407
Price currency
ILA
Rev Per Employee
618,727.04x
Sector
Healthcare
Sic
2836
Symbol
tlv/LCTX
Website
https://www.lineagecell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-20.46%
EV Earnings
-4.11x
EV/FCF
-13.42x
EV/Sales
19.72x
FCF yield
-6.26%
P/B ratio
7.17x
P/S ratio
21.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
-149.62%
EBITDA Margin
-144.82%
Gross margin
-22.8%
Gross Profit
ILA -10.6M
Net Income
ILA -202.5M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-471.61%
Profit Per Employee
ILA -2.7M
ROA
-12.06
Roa5y
-13.52
ROCE
-21.52
ROE
-105.3
Roe5y
-48.6
ROIC
-21.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr10y
-9.43%
Cagr1y
166.28%
Cagr3y
-8.69%
Cagr5y
-13.92%
EPS Growth Quarters
1
EPS Growth Years
0
Revenue Growth
53.24x
Revenue Growth Q
130.4x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
-0.33x
Revenue Growth5 Y
51.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
ILA 0.13
Assets
ILA 358.9M
Cash
ILA 177.8M
Current Assets
ILA 171.6M
Current Liabilities
ILA 33M
Debt
ILA 7.7M
Debt Equity
ILA 0.06
Debt FCF
ILA -0.12
Equity
ILA 138.2M
Liabilities
ILA 220.7M
Long Term Assets
ILA 187.3M
Long Term Liabilities
ILA 187.8M
Net Cash
ILA 170.1M
Net Cash By Market Cap
ILA 17.18
Net Cash Growth
17.82%
Net Debt Equity
ILA -1.23
Tangible Book Value
ILA 6.9M
Tangible Book Value Per Share
ILA 0.03
WACC
12.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
5.2
Net Working Capital
ILA -22.8M
Quick ratio
5.04
Working Capital
ILA 152.4M
Working Capital Turnover
ILA 1.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-14.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-62.86%
1Y total return
166.1%
200-day SMA
495.7
3Y total return
-23.86%
50-day SMA
500.8
50-day SMA vs 200-day SMA
50over200
5Y total return
-52.74%
All Time High
1,777
All Time High Change
-77.07%
All Time High Date
2015-12-31
All Time Low
13.01
All Time Low Change
3,031.44%
All Time Low Date
2015-09-08
ATR
24.48
Beta
1.6
Ch YTD
-20.43
High
429.2
High52
666
High52 Date
2025-11-03
High52ch
-38.83%
Low
400.2
Low52
153.1
Low52 Date
2025-05-08
Low52ch
166.1%
Ma50ch
-18.65%
Price vs 200-day SMA
-17.81%
RSI
31.49
RSI Monthly
48.91
RSI Weekly
38.29
Sharpe ratio
1.62x
Sortino ratio
3.02
Total Return
-14.95%
Tr YTD
-20.43
Tr1m
-16.92%
Tr1w
-7.97%
Tr3m
-18.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
ILA -69.4M
Operating margin
-149.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
187,279,449%
Net Borrowing
-171,159
Shares Insiders
5%
Shares Institutions
23.54%
Shares Qo Q
3.63%
Shares Yo Y
14.95%
Short Ratio
21.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
ILA -77.1M
Average Volume
5,576.75x
Bv Per Share
0.58
CAPEX
ILA -1.7M
Ch10y
-62.86
Ch1m
-16.92
Ch1w
-7.97
Ch1y
166.1
Ch3m
-18.26
Ch3y
-23.86
Ch5y
-52.74
Ch6m
-30.36
Change
-5.08%
Change From Open
-5.08
Close
429.2
Days Gap
0
Depreciation Amortization
2,027,799
Dollar Volume
3,117,424.8
Earnings Date
2026-05-12
EBIT
ILA -69.4M
EBITDA
ILA -67.2M
EPS
ILA -0.88
F Score
4
FCF
ILA -62M
FCF EV Yield
-7.45x
Financing CF
85,916,600
Fiscal Year End
December
Founded
1,990
Goodwill
30,959,472
Income Tax
ILA -16.8M
Investing CF
-42,900,916
Is Primary Listing
0
Last Earnings Date
2026-03-05
Last Report Date
2025-12-31
Ma150
533.9
Ma150ch
-23.7%
Ma20
461.6
Ma20ch
-11.74%
Net CF
-16,035,640
Next Earnings Date
2026-05-12
Open
429.2
Position In Range
24.83
Ppne
13,625,997
Price Date
2026-05-08
Ptbv Ratio
142.7
Relative Volume
1.38x
Revenue
46,404,528x
SBC By Revenue
32.65x
Share Based Comp
15,149,376
Tax By Revenue
-36.27x
Tr6m
-30.36%
Volume
7,652
Z Score
-3.73
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TLV/LCTX pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/LCTX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+166.1%
S&P 500 1Y: n/a
3Y total return
-23.9%
S&P 500 3Y: n/a
5Y total return
-52.7%
S&P 500 5Y: n/a
10Y total return
-62.9%
S&P 500 10Y: n/a
Ownership

Who owns TLV/LCTX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.5%
Share of float held by funds and institutions
Insider ownership
+5.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
21.1 days to cover
Y/Y dilution
+14.9%
Negative means the company is buying back shares.
Technical

TLV/LCTX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
31.5
Neutral momentum band
Price vs 200-day MA
-17.8%
50/200-day relationship not available
Beta (5Y)
1.60
More volatile than the market
Sharpe ratio
1.62
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TLV/LCTX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/LCTX stock rating?

tlv/LCTX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/LCTX analysis?

The full report lives at /stocks/tlv/LCTX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/LCTX?

The latest report frames tlv/LCTX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/LCTX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

tlv/LCTX stock profile: metrics, valuation and analysis | Tác nhân AI Thị trường Chứng khoán